Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $143 Million - $187 Million
3,614,900 New
3,614,900 $187 Million
Q1 2022

May 17, 2022

SELL
$61.48 - $73.72 $22 Million - $26.4 Million
-358,400 Reduced 13.75%
2,248,300 $164 Million
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $49.8 Million - $58.1 Million
-929,100 Reduced 26.28%
2,606,700 $163 Million
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $17.6 Million - $20.6 Million
297,400 Added 9.18%
3,535,800 $209 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $102 Million - $111 Million
1,648,900 Added 103.74%
3,238,400 $216 Million
Q1 2021

May 18, 2021

SELL
$59.34 - $66.74 $4.59 Million - $5.17 Million
-77,400 Reduced 4.64%
1,589,500 $100 Million
Q4 2020

Feb 17, 2021

SELL
$57.74 - $65.43 $8.63 Million - $9.78 Million
-149,500 Reduced 8.23%
1,666,900 $103 Million
Q3 2020

Nov 17, 2020

BUY
$57.43 - $63.64 $43.1 Million - $47.8 Million
751,100 Added 70.51%
1,816,400 $110 Million
Q2 2020

Aug 17, 2020

BUY
$54.82 - $64.09 $12.4 Million - $14.4 Million
225,400 Added 26.84%
1,065,300 $62.6 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $28.4 Million - $41.3 Million
612,500 Added 269.35%
839,900 $46.8 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $21.1 Million - $27.6 Million
-429,200 Reduced 65.37%
227,400 $14.6 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $6.98 Million - $8.28 Million
163,200 Added 33.08%
656,600 $33.3 Million
Q2 2019

Aug 15, 2019

SELL
$44.62 - $49.34 $18.5 Million - $20.5 Million
-414,500 Reduced 45.65%
493,400 $22.4 Million
Q1 2019

May 16, 2019

BUY
$45.12 - $53.8 $30.2 Million - $36.1 Million
670,200 Added 281.95%
907,900 $43.3 Million
Q4 2018

Feb 15, 2019

BUY
$48.76 - $63.23 $7.36 Million - $9.54 Million
150,900 Added 173.85%
237,700 $12.4 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $2.62 Million - $2.95 Million
-47,400 Reduced 35.32%
86,800 $5.39 Million
Q2 2018

Aug 15, 2018

BUY
$50.53 - $62.98 $4.25 Million - $5.3 Million
84,100 Added 167.86%
134,200 $7.43 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $725,032 - $834,658
12,100 Added 31.84%
50,100 $3.17 Million
Q4 2017

Feb 15, 2018

SELL
$59.94 - $65.35 $1.09 Million - $1.19 Million
-18,200 Reduced 32.38%
38,000 $2.33 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $3.1 Million - $3.58 Million
56,200
56,200 $3.58 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.